According to AstraZeneca's latest financial reports the company has a price-to-book ratio of 6.32.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | N/A | -100% |
2023-12-31 | 5.33 | -6.11% |
2022-12-31 | 5.68 | 22.91% |
2021-12-31 | 4.62 | -44.86% |
2020-12-31 | 8.38 | -6.58% |
2019-12-31 | 8.97 | 33.36% |
2018-12-31 | 6.72 | 28.42% |
2017-12-31 | 5.24 | 26.54% |
2016-12-31 | 4.14 | -11.43% |
2015-12-31 | 4.67 | 2.46% |
2014-12-31 | 4.56 | 43.05% |
2013-12-31 | 3.19 | 30.18% |
2012-12-31 | 2.45 | -3.97% |
2011-12-31 | 2.55 | -8.3% |
2010-12-31 | 2.78 | -15.01% |
2009-12-31 | 3.27 | -11.54% |
2008-12-31 | 3.70 | -11.59% |
2007-12-31 | 4.18 | -21.39% |
2006-12-31 | 5.32 | -6.66% |
2005-12-31 | 5.70 | 38.15% |
2004-12-31 | 4.13 | -33.21% |
2003-12-31 | 6.18 | 15.01% |
2002-12-31 | 5.37 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 5.30 | -16.15% | ๐บ๐ธ USA |
Novartis NVS | 5.04 | -20.29% | ๐จ๐ญ Switzerland |
Pfizer PFE | 1.72 | -72.71% | ๐บ๐ธ USA |
Abbott Laboratories ABT | 4.75 | -24.81% | ๐บ๐ธ USA |
Eli Lilly LLY | 68.0 | 976.08% | ๐บ๐ธ USA |
Sanofi SNY | 1.52 | -75.95% | ๐ซ๐ท France |
Biogen BIIB | 2.07 | -67.26% | ๐บ๐ธ USA |
Merck MRK | 8.67 | 37.23% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | 5.42 | -14.27% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | 5.38 | -14.79% | ๐ฌ๐ง UK |